Memorial Sloan Kettering CC
Dr. Daniel Heller
Associate Member of Molecular Pharmacology
Research summary
We are inventing novel technologies to treat advanced cancers and to detect disease at early stages. We are a young bioengineering laboratory that develops new nanotechnologies, including nanomedicines—tiny particles that target drugs to tumor sites, and nanosensors—tiny devices that detect markers of disease.